Question
click below
click below
Question
Normal Size Small Size show me how
WVSOM - Biochem
Cholesterol and Bile Acid Synthesis
Question | Answer |
---|---|
Cholesterol Synthesis Starting materials | Acetyl CoA NADPH ATP |
HMG-CoA reductase | rate limiting step (target of drug therapy) |
Products of cholesterol synthesis | Cholesterol NADP+ ADP |
Location of Cholesterol synthesis | hepatocytes |
regulated enzyme of cholesterol synthesis | HMG CoA reductase |
Increasing levels of cholesterol __________ cholesterol synthesis | decreases |
HMG CoA is active when | dephosphorylated |
HMG CoA is dephosphorylated with ___________ insulin to glucagon levels. | high |
HMG CoA is inactivated by ____________ and is then _____________ | Glucagon; phosphorylated |
Most significant factor in regulation of cholesterol biosynthesis | decreasing HMG CoA reductase synthesis |
Proteolysis of HMG CoA reductase increases as ____________ | sterol levels rise |
Which drug class inhibits this enzyme | statins |
Extrahepatic cholesterol synthesis | occurs under certain pathological conditions |
Why is cholesterol esterified | regulation |
where is cholesterol esterified | on lipoprotiens and in cells |
How does esterification change regulation | cholesterol ester CANNOT regulate HMG CoA reductatse |
Two enzymes that esterize cholesterol | LCAT (Lecithin) ACAT (acyl CoA) |
LCAT | Esterifies cholesterol on lipoprotein that can be transferred from HDL to LDL |
ACAT | esterifies cholesterol within the cell |
Extrahepatic cholesterol synthesis | under certain pathological conditions |
Where are cholesterol esterified/de-esterified in cells? | lipoproteins |
Esterifcation of cholesterol | changes the properties of cholesterol especially with regard to its control functions |
LCAT | Lecithin: chelesterol acyl transferase Esteerifies cholesterol on lipoproteins |
What is transfered to LDL and HDL | Esterfied cholesterol |
ACAT | esterfies cholesterol within the cell |
Cholesterol esterase | reveses LCAT and ACAT esterification |
Bile Salt Synthesis Location | hepatocytes |
Starting compounds of Bile Salts | Cholesterol, ATP, NADPH |
4 conjugated bile salts | taurocholic glycocholic taurochenocholic glycohenocholic acids |
Conjugation of bile salts increases ____________ | solubility |
Solubility enables bile salts to act as | detergents |
Conjugated bile salts composed of | primary bile salts, cholic acids and chenocholic ascid conjugated to taurine or glycine which are hydrophobic |
How much bile salts are recycled | > 95% |
Liver synthesis of bile acid _____ g/day | .2 - .6 |
Amount of bile salts reabsorbed | 12-32 g/day |
bile removed by feces | .2-.6 g/day |
Why would we want to decrease bile salt reabsorption | drugs which bind to bile acids prevent their reabsorption to increase cholesterol excretion |
Cholesterol esterase | reverses LCAT and ACAT by de-esterifying cholesterol |
Bile Salt Exrection | in feces |
Primary Bile Salts | chenocholic acid and chlic acid |
Location of bile acid synthesis | hepatocytes |
starting compounds of bile acid synthesis | cholesterol ATP NADPH |
Controlled step of bile acid salts | products and substrate!!!! |
Products of bile acid synthesis | cholic acid and chenocholic acids |
Conjugated bile salts | primary bile salts bound to hydrophobic taurine or glycine |
4 conjugated bile salts | taurocholic glycocholic taurochenocholic glyochenocholic acids |
Bile Salts recycled | > 95% 12-32 g/day |
Why would we want to pharmachologically bind drugs to bile acids | to prevent reabsorption to increase cholesterol excretion |